Healthcare & Life Sciences
Adrenomed
Germanywww.adrenomed.com/
Adrenomed is a Healthcare & Life Sciences startup based in Germany, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
2009
Founded
1
Investors
About Adrenomed
Based in Germany, Adrenomed is a startup founded in 2009. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Adrenomed is a clinical-stage biopharmaceutical company based in Germany. It develops novel therapies, including its lead product Adrecizumab, for life-threatening conditions like septic shock.
Explore Adrenomed's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.